Introduction {#s1}
============

The benefits of antiretroviral therapy (ART) in reducing HIV/AIDS related-morbidity and mortality are extensively documented [@pone.0085327-Joint1]--[@pone.0085327-Brinkhof1]. Recent evidence indicates that early initiation of ART substantially reduces sexual transmission of HIV at individual [@pone.0085327-Cohen1], [@pone.0085327-Baeten1] and population levels [@pone.0085327-Tanser1]; conferring ART a crucial place in both treatment and prevention of HIV/AIDS.

Prior studies have shown that, without high and sustained adherence levels, both therapeutic and public health benefits of ART cannot be secured, and that individuals with sub-optimal levels of adherence have higher risk of incomplete viral suppression, disease progression, and development of drug resistance [@pone.0085327-Sethi1]--[@pone.0085327-Lima1].

Our understanding of adherence to ART has substantially increased over the past years with a wide documented range of factors influencing ART adherence across differing settings in developed and developing countries [@pone.0085327-Balcha1]--[@pone.0085327-Wanyama1]. Recently, food insecurity has emerged as a key structural barrier that affects adherence to ART in both resource-rich and constrained settings. Studies from British Columbia [@pone.0085327-Weiser1], San Francisco [@pone.0085327-Weiser2], Atlanta [@pone.0085327-Kalichman1], [@pone.0085327-Kalichman2], and France [@pone.0085327-PerettiWatel1] have found lower levels of medication adherence among food insecure individuals on ART. Similarly, a number of, predominantly qualitative, studies from Sub-Saharan Africa (SSA) have documented food insecurity as an important barrier to ART adherence [@pone.0085327-Sanjobo1], [@pone.0085327-Musumari1]--[@pone.0085327-Weiser4]. Furthermore, food insecurity was shown to be independently related to poor virologic response and mortality even when adjusting for patient adherence to ART [@pone.0085327-Weiser2], [@pone.0085327-Wang1], [@pone.0085327-Weiser5].

Food insecurity parallels, and is viciously intertwined with the AIDS epidemic in SSA, both having a damaging impact in the region [@pone.0085327-World1]. SSA accounts for 69% of the people infected with HIV worldwide, and is home to 234 million (26.8%) people classified as undernourished [@pone.0085327-Joint1], [@pone.0085327-Food1]. In the Democratic Republic of Congo (DRC), the research setting of the current study, the Multi Indicator Cluster Survey (MICS) revealed that approximately 33% of the households were experiencing food insecurity in 2010, with figures ranging from 5% in the Kinshasa City to nearly 60% in some eastern provinces of the DRC [@pone.0085327-Institut1]. The national HIV program reports a HIV prevalence of 2.57% among the general population, with only 12.3% of eligible patients having access to ART [@pone.0085327-Programme1].

A review of the literature revealed that, unlike in resource-rich settings, very few quantitative studies to date, using a validated measure of food insecurity, have documented the association between food insecurity and patient adherence to ART in SSA and the developing world at large [@pone.0085327-Weiser4], [@pone.0085327-Young1]. Additionally, literature on patient adherence to ART in the DRC, the second largest country in Africa, remains exceptionally scarce. In our preliminary qualitative study, we found that food insecurity, financial constraints, forgetfulness, and fear of disclosure/stigma were common barriers to ART adherence; while religious beliefs were both a barrier and facilitator of ART adherence among HIV-positive adults in the DRC [@pone.0085327-Musumari1].

The current study, grounded in the results of our qualitative study [@pone.0085327-Musumari1], aims at quantitatively assessing factors associated with adherence and more specifically, documenting the prevalence of food insecurity, and its effect on ART adherence among HIV-positive adults receiving ART in the DRC. Such information is crucial for guiding context-specific interventions to promote patient adherence to ART.

Methods {#s2}
=======

Ethics Statement {#s2a}
----------------

This study was granted ethical approval from the Committee for Research on Human Subjects at Kyoto University and the Kinshasa University School of Public Health Ethics Review Committee in the DRC. All the participants provided written informed consents before being interviewed.

Study Design, Participants and Setting {#s2b}
--------------------------------------

This is a cross-sectional study conducted in Kinshasa, DRC, between April and November 2012. Participants were consecutively recruited into the study from one public health facility: Hopital Provincial General de Référence de Kinshasa (HGPRK) and three private health institutions which included one treatment site of the NGO Actions Communautaires Sida/Avenir Meilleur pour les Orphelins (ACS/Amo-Congo), three treatment sites of the Armée du salut (Salvation Army), and two treatment sites of the Centre Hospitalier Monkole (CHM). Recruitment sites were in geographically dispersed locations and served patients coming from all the townships of Kinshasa. At the time the study was conducted, around 1,000, 2,900, 2,300, and 1,100 patients were receiving free ART respectively at the HGPRK, ACS/Amo-Congo, Armée du salut, and the CHM, and none of the facilities provided food or any kind of nutrition aid to patients. We collected data using an interviewer-administered questionnaire, which we designed based on the findings from our prior qualitative study [@pone.0085327-Musumari1] supplemented with other relevant questions obtained from the available literature [@pone.0085327-Godin1]--[@pone.0085327-Wouters1]. The questionnaire was piloted in a sample of 20 respondents (not included in the final sample) to ensure clarity prior to conducting interviews, and it showed an overall good test-retest reliability performed within a one month interval. The interviews were conducted in French or Lingala, the most commonly used languages in Kinshasa, and the interviewers were provided guidance on questionnaire administration over two training sessions organized by the research team. Participants were included in the study provided that they were at least 18 years old, on ART for at least 6 months, and had given written informed consent. Participants were compensated for their time and transportation with an amount of 3 US dollars.

Measures {#s2c}
--------

### Primary outcome {#s2c1}

The primary outcome of interest was adherence to ART, and was assessed using a composite measure coupling both pharmacy refill and self-reported adherence. Pharmacy refill adherence measures were shown to be reliable in assessing adherence, and to correlate well with virological and clinical outcomes in resource limited settings [@pone.0085327-McMahon1]--[@pone.0085327-Weidle1], and the combination with self-reported adherence performed better in predicting virological failure than other singular methods [@pone.0085327-Nguyen1].

The pharmacy refill adherence in this study is based on a variation of the medication possession ratio (MPR), a measure of the proportion of days a patient has his/her medication on hand, and was calculated by dividing the number of days late for pharmacy refills by the total days on ART, and then subtracting this proportion from 100% [@pone.0085327-Chi1], [@pone.0085327-Goldman1]. We calculated the average pharmacy refill rate of adherence for each patient over the preceding six months. When applicable, the number of days being late for pharmacy refills was adjusted to account for cases where patients were provided with more medication than needed. Patients with pharmacy adherence levels \<95% were categorized as non-adherent to ART [@pone.0085327-Paterson1].

To measure self-reported adherence, we adopted a validated tool that assesses adherence over the previous seven days [@pone.0085327-Godin1]. The tool contains questions that first measure adherence over shorter time frames (yesterday and the day before yesterday), and an aided-recall question for situations that can potentially lead to missed ART doses with the intent to facilitate a more accurate reporting of the number of pills skipped during the previous seven days, and to limit the influence of forgetfulness. Self-reported non-adherence was defined as taking \<95% of the prescribed pills over the previous seven days [@pone.0085327-Paterson1].

In this study, participants were categorized as non-adherent to ART when they were non-adherent to either one or both of the measures of adherence described above; otherwise, they were considered to be adherent.

### Primary independent variable {#s2c2}

Food insecurity was the primary independent variable of this study, and was measured by the Household Food Insecurity Access Scale (HFIAS) [@pone.0085327-Coates1]. The HFIAS is a validated instrument and has been shown to distinguish food insecure from food secure households across different cultural contexts. It is a set of nine questions designed to reflect universal domains of the experience of food insecurity including 1) anxiety and uncertainty about the household food supply, 2) insufficient quality (includes variety and preferences of the type of food), and 3) insufficient food intake and its physical consequences. We presented results in a categorical format including 1) food secure, 2) mildly food insecure 3) moderately food insecure, and 4) severely food insecure, which we dichotomized into food insecure versus food secure. The Cronbach's alpha was 0.97, demonstrating a high internal consistency of the scale in our sample.

### Other covariates {#s2c3}

***Internalized AIDS stigma***: The Internalized AIDS-Related Stigma Scale was used to assess the internalized AIDS stigma [@pone.0085327-Kalichman3]. The items were administered on a 5-point Likert-scale ranging from strongly disagree to strongly agree. Strongly disagree, disagree, and neutral were converted to 0 and agree and strongly agree to 1. Scale score ranged 0--6; participants who obtained relatively high scores on the scale (\>2) were compared to those who had low scores (≤2) [@pone.0085327-Peltzer1]. The scale showed a moderate degree of internal consistency with Cronbach's alpha = 0.60.

***Psychological distress (Depression, anxiety disorders)***: Mental health status was assessed using the Kessler-6 scale, a standardized and validated screening tool for non-specific psychological distress including depression and anxiety disorders [@pone.0085327-Kessler1]. Participants were asked on a 5-points Likert scale ranging from 0 (none of the time) to 4 (all of the time) how often they felt 1) nervous, 2) hopeless, 3) restless or fidgety, 4) so depressed that nothing could cheer you up, 5) that everything was an effort, and 6) worthless. Scores equal to or higher than 13 indicate higher probability of psychological distress. There was a high internal consistency of the scale in our sample with Cronbach's alpha = 0.89.

***Other variables***: other covariates included the household wealth index [@pone.0085327-Filmer1], socio-demographic characteristics (10 items), HIV/AIDS disease-related variables (4 items) and HIV/AIDS knowledge (8 items), ART-related variables (8 items), perceptions about HIV/AIDS and ART (12 items), alcohol and drug use (2 items), social support [@pone.0085327-Heaney1], and perceived quality of health care (6 items) [@pone.0085327-Wouters1]. (See [Text S1](#pone.0085327.s004){ref-type="supplementary-material"} for additional information on variables).

Statistical Analysis {#s2d}
--------------------

Data was analyzed using SPSS (PASW) for Windows 17.0 (SPSS Inc., Chicago, Illinoi, USA). Univariate analysis was conducted to obtain descriptive statistics of all the variables. Bivariate analyses were performed using Chi-square tests for categorical variables and Mann Whitney U-test for continuous variables. We included in the analysis nonresponse cases on items related to perceptions about HIV/AIDS and ART; their exclusion did not affect the results of our analysis (See [Table S1](#pone.0085327.s001){ref-type="supplementary-material"}, which shows frequency of nonresponse for perception items). We grouped nonresponses with participants whose answers were "disagree" and "don't know" since they were similar with respect to their odds ratios when compared to participants who agreed to the assertions. Factors associated with non-adherence by bivariate analysis with P value ≤0.10 and those considered epidemiologically important were entered into a multivariate logistic regression model to obtain adjusted odds ratios (AOR) and 95% confidence intervals (CI). "Frequency of ART" and "regimen drugs" were not included in the multivariate model, even though both variables had each a category with P value ≤0.10, overall the two variables did not meet the inclusion criteria, and we excluded "duration of HIV infection" from the model because of its multicollinearity with "duration of ART".

Results {#s3}
=======

Participant Characteristics {#s3a}
---------------------------

A total of 898 participants completed the study and 25 declined participation, giving a response rate of 97.3%. The median age was 44 years \[Interquartile range (IQR): 38--51\]. The majority of participants were female (72.2%), without standard employment (76.4%), had completed at least secondary school (75.3%), and Christians (87.9%) by religion ([Table 1](#pone-0085327-t001){ref-type="table"}). The median treatment duration was 41 months (IQR: 18--64); most participants were on first line regimens (97.9%), and on a twice a day dosing schedule (92.3%). ([Table 2](#pone-0085327-t002){ref-type="table"}).

10.1371/journal.pone.0085327.t001

###### Sociodemographic characteristics of non-adherent and adherent participants on ART recruited in Kinshasa, DRC.

![](pone.0085327.t001){#pone-0085327-t001-1}

                                                               Non-Adherent (n = 188)    Adherent (n = 710)      Total (n = 898)      Crude OR (95% CI)   P value
  ----------------------------------------------------------- ------------------------ ---------------------- ---------------------- ------------------- ---------
  **Gender**                                                                                                                                             
  Male                                                               49 (26.1)               201 (28.3)             250 (27.8)              1.00         
  Female                                                             139 (73.9)              509 (71.7)             648 (72.2)        1.12 (0.77--1.61)    0.603
  **Educational level**                                                                                                                                  
  Primary school or less                                             46 (24.5)               176 (24.8)             222 (24.7)              1.00         
  Secondary school                                                   110 (58.5)              420 (59.2)             530 (59.0)        1.00 (0.68--1.47)    1.000
  University                                                         32 (17.0)               114 (16.0)             146 (16.3)        1.07 (0.64--1.78)    0.885
  **Marital status**                                                                                                                                     
  Married/cohabitating                                               63 (33.5)               261 (36.8)             324 (36.1)              1.00         
  Single                                                             43 (22.9)               164 (23.1)             207 (23.1)        1.08 (0.70--1.67)    0.793
  Divorced/Separated                                                 29 (15.4)               83 (11.7)              112 (12.5)        1.44 (0.87--2.39)    0.191
  Widowed                                                            53 (28.2)               202 (28.4)             255 (28.4)        1.08 (0.72--1.63)    0.768
  **Religion**                                                                                                                                           
  Catholic Christian                                                 54 (28.7)               194 (27.3)             248 (27.6)              1.00         
  Protestant Christian                                               22 (11.7)               125 (17.6)             147 (16.4)        0.63 (0.36--1.09)    0.127
  Revival churches Christian                                         85 (45.2)               309 (43.5)             394 (43.9)        0.98 (0.67--1.45)    1.000
  Others[\*](#nt101){ref-type="table-fn"}                            27 (14.4)               82 (11.5)              109 (12.1)        1.18 (0.69--2.00)    0.627
  **Employment status**                                                                                                                                  
  Employed                                                           37 (19.7)               175 (24.6)             212 (23.6)              1.00         
  Unemployed                                                         151 (80.3)              535 (75.4)             686 (76.4)        1.33 (0.89--1.98)    0.184
  **IGA**                                                                                                                                                
  Yes                                                                136 (72.3)              478 (67.3)             614 (68.4)              1.00         
  No                                                                 52 (27.7)               232 (32.7)             284 (31.6)        0.78 (0.55--1.12)    0.220
                                                                    Median (IQR)            Median (IQR)           Median (IQR)                          
  **Age (years)**                                                 43 (36. 25--50)           44 (38--51)            44 (38--51)                             0.150
  **Household size**                                                  5 (4--7)                5 (3--7)               5 (3--7)                              0.426
  **Financial dependents** [†](#nt102){ref-type="table-fn"}         3 (1.25--5)               3 (1--5)               3 (1--5)                              0.820
  **Household wealth index**                                    0.08 (−2.29 to 2.55)    0.16 (−2.44 to 2.42)   0.16 (−2.43 to 2.42)                        0.823

Other: Muslim, Kimbaguist, None;

number of financial dependents; ART, antiretroviral therapy; IGA, income generating activity; OR, odds ratio; IQR, inter-quartile range; DRC, Democratic Republic of Congo.

10.1371/journal.pone.0085327.t002

###### Bivariate analysis of factors associated with Non-adherence to ART.

![](pone.0085327.t002){#pone-0085327-t002-2}

                                                                 Non-Adherent (n = 188)   Adherent (n = 710)   Total (n = 898)   Crude OR (95% CI)    p value
  ------------------------------------------------------------- ------------------------ -------------------- ----------------- -------------------- ---------
  **Food insecurity**                                                                                                                                
  No                                                                   53 (28.2)              333 (46.9)         386 (43.0)             1.00         
  Yes                                                                  135 (71.8)             377 (53.1)         512 (57.0)      2.25 (1.58--3.19)     0.000
  **Disclosure**                                                                                                                                     
  No                                                                   36 (19.1)              170 (24.0)         206 (22.9)             1.00         
  Yes                                                                  152 (80.9)             540 (76.0)         692 (77.1)      1.32 (0.88--1.98)     0.196
  **Psychological distress**                                                                                                                         
  No (Score:0--12)                                                     183 (97.3)             663 (93.4)         846 (94.2)             1.00         
  Yes (Score:13--24)                                                    5 (2.7)                47 (6.6)           52 (5.8)       0.38 (0.15--0.98)     0.039
  **Internalized stigma**                                                                                                                            
  Score:0--2                                                           123 (65.4)             483 (68.0)         606 (67.5)             1.00         
  Score:3--6                                                           65 (34.6)              227 (32.0)         292 (32.5)      1.12 (0.80--1.57)     0.555
  **Social support from family**                                                                                                                     
  No                                                                   96 (51.1)              417 (58.7)         513 (57.1)             1.00         
  Yes                                                                  92 (48.9)              293 (41.3)         385 (42.9)      1.36 (0.98--1.88)     0.071
  **Social support from non-family members**                                                                                                         
  No                                                                   137 (72.9)             544 (76.6)         681 (75.8)             1.00         
  Yes                                                                  51 (27.1)              166 (23.4)         217 (24.2)      1.22 (0.84--1.75)     0.331
  **Opportunistic infection**                                                                                                                        
  No                                                                   181 (96.3)             683 (96.2)         864 (96.2)             1.00         
  Yes                                                                   7 (3.7)                27 (3.8)           34 (3.8)       0.97 (0.41--2.28)     1.000
  **HIV-infected individual(s) in the household**                                                                                                    
  No                                                                   160 (85.1)             554 (78.0)         714 (79.5)             1.00         
  Yes                                                                  28 (14.9)              156 (22.0)         184 (20.5)      0.62 (0.40--0.96)     0.042
  **Alcohol intake** [\*](#nt103){ref-type="table-fn"}                                                                                               
  No                                                                   139 (73.9)             585 (82.4)         724 (80.6)             1.00         
  Yes                                                                  49 (26.1)              125 (17.6)         174 (19.4)      1.65 (1.13--2.40)     0.012
  **Tobacco smoking**                                                                                                                                
  No                                                                   179 (95.2)             680 (95.8)         859 (95.7)             1.00         
  Yes                                                                   9 (4.8)                30 (4.2)           39 (4.3)       1.14 (0.53--2.44)     0.893
  **Knowledge of HIV/AIDS**                                                                                                                          
  Good (≥5)                                                            164 (87.2)             622 (87.6)         786 (87.5)             1.00         
  Poor (≤4)                                                            24 (12.8)              88 (12.4)          112 (12.5)      1.03 (0.63--1.67)     0.990
  **Regimen**                                                                                                                                        
  1st line                                                             184 (97.9)             695 (97.9)         879 (97.9)             1.00         
  2nd line                                                              4 (2.1)                15 (2.1)           19 (2.1)       1.00 (0.33--3.07)     1.000
  **Regimen drugs**                                                                                                                                  
  3TC+TDF+EFV or NVP                                                    10 (5.3)               67 (9.4)           77 (8.6)              1.00         
  3TC+AZT+EFV or NVP or LPV/rit                                        165 (87.8)             575 (81.0)         740 (82.4)      1.92 (0.96--3.82)     0.080
  3TC+D4T+EFV or NVP                                                    9 (4.8)                53 (7.5)           62 (6.9)       1.13 (0.43--3.00)     0.990
  ABC+DDI+LPV/r                                                         4 (2.1)                15 (2.1)           19 (2.1)       1.78 (0.49--6.47)     0.597
  **Pill burden**                                                                                                                                    
  1--4                                                                 169 (89.9)             650 (91.5)         819 (91.2)             1.00         
  ≥5                                                                   19 (10.1)               60 (8.5)           79 (8.8)       1.21 (0.70--2.09)     0.570
  **Frequency of ART**                                                                                                                               
  Once/day                                                              5 (2.7)                45 (6.3)           50 (5.6)              1.00         
  Twice/day                                                            179 (95.2)             650 (91.5)         829 (92.3)      2.47 (0.96--6.33)     0.075
  Thrice/day                                                            4 (2.1)                15 (2.1)           19 (2.1)       2.40 (0.56--10.11)    0.247
  **Refill Schedule**                                                                                                                                
  Every 2 or 3 months                                                  43 (22.9)              204 (28.7)         247 (27.5)             1.00         
  Every month                                                          145 (77.1)             506 (71.3)         651 (72.5)      1.35 (0.93--1.98)     0.132
  **Duration of HIV infection**                                                                                                                      
  \<48 months                                                          76 (40.4)              342 (48.2)         418 (46.5)             1.00         
  ≥48 months                                                           112 (59.6)             368 (51.8)         480 (53.5)      1.37 (0.98--1.89)     0.070
  Median (IQR)                                                        48 (24--72)            48 (24--72)         48 (24--72)                         
  **Duration of ART**                                                                                                                                
  \<48 months                                                          94 (50.0)              421 (59.3)         515 (57.3)             1.00         
  ≥48 months                                                           94 (50.0)              289 (40.7)         383 (42.7)      1.45 (1.05--2.01)     0.027
  Median (IQR)                                                        48.5(24--72)           40 (18--62)         41 (18--64)                         
  **Perceived quality of care**                                                                                                                      
  Not satisfied (0--2)                                                  10 (5.3)               23 (3.2)           33 (3.7)              1.00         
  Moderately satisfied (3--4)                                          22 (11.7)              86 (12.1)          108 (12.0)      0.58 (0.24--1.41)     0.340
  Highly satisfied (5--6)                                              156 (83.0)             601 (84.6)         757 (84.3)      0.59 (0.27--1.28)     0.263
  **Treatment sites**                                                                                                                                
  HPGRK                                                                 13 (6.9)              86 (12.1)           99 (11.0)             1.00         
  ACS/AMO CONGO                                                        94 (50.0)              208 (29.3)         302 (33.6)      2.99 (1.58--5.62)     0.001
  MONKOLE                                                              35 (18.6)              165 (23.2)         200 (22.3)      1.40 (0.70--2.79)     0.423
  ARMEE DU SALUT                                                       46 (24.5)              251 (35.4)         297 (33.1)      1.21 (0.62--2.35)     0.684
  **Travel time (in hours)** [†](#nt104){ref-type="table-fn"}                                                                                        
  \<1                                                                  103 (54.8)             398 (56.1)         501 (55.8)             1.00         
  1--\<2                                                               66 (35.1)              251 (35.3)         317 (35.3)      1.01 (0.71--1.43)     0.999
  ≥2                                                                   19 (10.1)               61 (8.6)           80 (8.9)       1.20 (0.68--2.10)     0.615

Defined as alcohol consumption at least once a month;

travel time from home to health facility expressed in hour(s); ART, antiretroviral therapy; OR, odds ratio; CI, confidence interval; 3TC = Lamivudine; TDF = Tenofovir; EFV = Efavirenz; NVP = Nevirapine; AZT = Zidovudine; LPV/r = Lopinavir/Ritonavir, D4T = Stavudine, ABC = Abacavir; DDI = Didanosine; IQR, inter-quartile range; HPGRK, Hopital Provincial General de Référence de Kinshasa; ACS/AMO Congo, Actions Communautaires Sida/Avenir meilleur pour les orphelins.

Food Insecurity and Adherence Assessment {#s3b}
----------------------------------------

Based on the HFIAS, 386 participants (43.0%) were classified as food secure, 9 (1.0%) as mildly food insecure, 46 (5.1%) as moderately food insecure and 457 (50.9%) as severely food insecure (See [Table S2](#pone.0085327.s002){ref-type="supplementary-material"}, which shows details of participants' food security status). The overall prevalence of food insecurity among our participants was 57% ([Table 2](#pone-0085327-t002){ref-type="table"}). 188 (20.9%) participants were categorized as non-adherent to ART in respect to the definition of adherence described above (See [Table S3](#pone.0085327.s003){ref-type="supplementary-material"}, which shows details of participants' adherence status).

Bivariate Associations between Independent Variables and ART Adherence {#s3c}
----------------------------------------------------------------------

Factors significantly associated with non-adherence in the bivariate analysis included food insecurity \[odds ratio (OR), 2.25; CI, 1.58--3.19; *P* = 0.000)\], psychological distress (OR, 0.38; CI, 0.15--0.98; *P* = 0.039), presence of (an)other HIV-infected individual(s) in the household (OR, 0.62; CI, 0.40--0.96; *P* = 0.042), alcohol intake (OR, 1.65; CI, 1.13--2.40; *P* = 0.012), duration of ART \[≥48 months\] (OR, 1.45; CI, 1.05--2.01; *P* = 0.027), perceived ART harmfulness (OR, 1.68; CI, 1.10--2.55; *P* = 0.042), and the beliefs that God or prayers could cure HIV (OR, 2.10; CI, 1.45--3.04; *P* = 0.000), or that ART worked better when associated with prayers (OR, 1.73; CI, 1.23--2.43; *P* = 0.002), and receiving treatment from ACS/Amo-Congo (OR, 2.99; CI, 1.58--5.62; *P* = 0.001). ([Table 2](#pone-0085327-t002){ref-type="table"} & [Table 3](#pone-0085327-t003){ref-type="table"}).

10.1371/journal.pone.0085327.t003

###### Perceptions about HIV/AIDS and ART.

![](pone.0085327.t003){#pone-0085327-t003-3}

                                                                                 Non-Adherent (n = 188)   Adherent (n = 710)   Total (n = 898)   Crude OR (95% CI)   P value
  ----------------------------------------------------------------------------- ------------------------ -------------------- ----------------- ------------------- ---------
  ***Sociocultural/Religious beliefs***                                                                                                                             
  **God/prayer can cure HIV**                                                                                                                                       
  Agree                                                                                143 (76.1)             427 (60.1)         570 (63.5)      2.10 (1.45--3.04)    0.000
  Else                                                                                 45 (23.9)              283 (39.1)         328 (36.5)            1.00         
  **Traditional healers/medicine can cure HIV**                                                                                                                     
  Agree                                                                                 9 (4.8)                35 (4.9)           44 (4.9)       0.97 (0.45--2.05)    1.000
  Else                                                                                 179 (95.2)             675 (95.1)         854 (95.1)            1.00         
  **ART works better when combined with prayers**                                                                                                                   
  Agree                                                                                126 (67.0)             383 (53.9)         509 (56.7)      1.73 (1.23--2.43)    0.002
  Else                                                                                 62 (33.0)              327 (46.1)         389 (43.3)            1.00         
  ***Perceptions about ART and food***                                                                                                                              
  **ART is not necessary without food**                                                                                                                             
  Agree                                                                                37 (19.7)              154 (21.7)         191 (21.3)      0.88 (0.59--1.32)    0.618
  Else                                                                                 151 (80.3)             556 (78.3)         707 (78.7)            1.00         
  **ART is not effective without food**                                                                                                                             
  Agree                                                                                20 (10.6)              77 (10.8)           97 (10.8)      0.97 (0.58--1.64)    1.000
  Else                                                                                 168 (89.4)             633 (89.2)         801 (89.2)            1.00         
  **ART can be harmful without food**                                                                                                                               
  Agree                                                                                58 (30.9)              220 (31.0)         278 (31.0)      0.99 (0.79--1.40)    1.000
  Else                                                                                 130 (69.1)             490 (69.0)         620 (69.0)            1.00         
  ***Perceptions about ART adherence***                                                                                                                             
  **Short treatment interruption is not harmful** **to a long-term ART user**                                                                                       
  Agree                                                                                 10 (5.3)              71 (10.0)           81 (9.0)       0.50 (0.25--1.00)    0.064
  Else                                                                                 178 (94.7)             639 (90.0)         817 (91.0)            1.00         
  **Skipping few ART doses is not harmful** **to a long-term ART user**                                                                                             
  Agree                                                                                 10 (5.3)               48 (6.8)           58 (6.5)       0.77 (0.38--1.56)    0.584
  Else                                                                                 178 (94.7)             662 (93.2)         840 (93.5)            1.00         
  **Skipping ART doses can worsen the disease**                                                                                                                     
  Agree                                                                                135 (71.8)             434 (61.1)         569 (63.4)      0.69 (0.46--1.03)    0.087
  Else                                                                                 53 (28.2)              276 (38.9)         329 (36.6)            1.00         
  **ART should be taken life-long**                                                                                                                                 
  Agree                                                                                172 (91.5)             651 (91.7)         823 (91.6)      1.00 (0.45--2.23)    1.000
  Else                                                                                  16 (8.5)               59 (8.3)           75 (8.4)             1.00         
  ***Perceptions about ART***                                                                                                                                       
  **Perceived effectiveness of ART**                                                                                                                                
  Yes                                                                                  176 (93.6)             630 (88.7)         806 (89.8)      1.86 (0.99--3.49)    0.067
  No                                                                                    12 (6.4)              80 (11.3)           92 (10.2)            1.00         
  **Perceived ART harmfulness**                                                                                                                                     
  Yes                                                                                  29 (15.4)               70 (9.9)           99 (11.0)      1.68 (1.10--2.55)    0.042
  No                                                                                   159 (84.6)             640 (90.1)         799 (89.0)            1.00         

ART, antiretroviral therapy; OR, odds ratio; CI, confidence interval.

[Table 4](#pone-0085327-t004){ref-type="table"} shows reasons reported by participants for skipping ART doses during the previous seven days. 36 (39.5%) participants cited forgetfulness, 17 (18.6%) were unable to pay for the medical consultation or for transport, 13 (14.2%) ran out of pills, 11 (12.0%) reported lack of food, 7 (7.6%) had travelled, and other reasons were reported in much lower proportions.

10.1371/journal.pone.0085327.t004

###### Reasons for missing ART doses during the previous seven days.
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  Reason                                              Frequency (n = 91)    \%
  -------------------------------------------------- -------------------- ------
  Forgetfulness                                               36           39.5
  Unable to pay for transport/medical consultation            17           18.6
  Ran out of pills                                            13           14.2
  Lack of food                                                11            12
  Travel                                                      7            7.6
  Pill fatigue                                                3            3.2
  Alcohol                                                     2            2.1
  Away from home                                              2            2.1
  Side effects                                                1            1.1
  Felt tired                                                  1            1.1
  Felt depressed                                              1            1.1
  Fell asleep                                                 1            1.1

ART, antiretroviral therapy; Multiple responses are possible.

Multivariate Analysis {#s3d}
---------------------

In the multivariate analysis ([Table 5](#pone-0085327-t005){ref-type="table"}), food insecurity was strongly associated with non-adherence. Food insecure participants were two times more likely to be non-adherent to ART compared to those who were food secure (AOR, 1.99; CI, 1.36--2.90, *P* = 0.000). Other factors significantly associated with non-adherence to ART included alcohol intake (AOR, 1.55; CI, 1.02--2.34, *P* = 0.037), and perceived ART harmfulness (AOR, 2.06; CI, 1.30--3.27, *P* = 0.002). Paradoxically, we found that participants who had psychological distress (depression, anxiety) as measured by the K6-scale, had lower odds of non-adherence (AOR, 0.34; CI, 0.12--0.90, *P* = 0.030), as well as those who reported that skipping ART doses could worsen the disease (AOR, 0.58; CI, 0.38--0.88, *P* = 0.012).

10.1371/journal.pone.0085327.t005

###### Multivariate analysis of factors associated with non-adherence to ART.
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                                                                                         Adjusted OR     95% CI      P value
  ------------------------------------------------------------------------------------- ------------- ------------- ---------
  Food insecurity yes (vs no)                                                               1.99       1.36--2.90     0.000
  Alcohol intake yes (vs no)                                                                1.55       1.02--2.34     0.037
  Internalized stigma score:3--6 (vs score:0--2)                                            1.11       0.76--1.61     0.571
  Social support from family yes (vs no)                                                    1.26       0.90--1.78     0.174
  Psychological distress yes (vs no)                                                        0.34       0.12--0.90     0.030
  Duration of ART ≥48 months (vs \<48 months)                                               1.27       0.90--1.80     0.170
  Perceived ART harmfulness yes (vs no)                                                     2.06       1.30--3.27     0.002
  Perceived effectiveness of ART yes (vs no)                                                1.19       0.16--8.93     0.859
  Short treatment interruption is not harmful to a long-term ART user Agree (vs else)       0.55       0.27--1.14     0.110
  Skipping ART doses can worsen the disease Agree (vs else)                                 0.58       0.38--0.88     0.012
  God/prayer can cure HIV/AIDS Agree (vs else)                                              1.48       0.92--2.37     0.098
  ART works better when combined with prayer Agree (vs else)                                1.01       0.64--1.59     0.952
  HIV-infected person(s) in the household Yes (vs no)                                       0.72       0.45--1.15     0.173
  Treatment sites                                                                                                   
  HPGRK                                                                                     1.00                    
  ACS/AMO CONGO                                                                             1.87       0.26--13.34    0.531
  MONKOLE                                                                                   0.98       0.13--7.07     0.988
  ARMEE DU SALUT                                                                            0.77       0.10--5.47     0.798

ART, antiretroviral therapy; OR, odds ratio; CI, confidence interval; HPGRK, Hopital Provincial General de Référence de Kinshasa; ACS/AMO CONGO, Actions Communautaires Sida/Avenir Meilleur pour les Orphelins.

Discussion {#s4}
==========

Designed based on the findings of our preceding qualitative study that food insecurity is a prominent structural barrier to ART adherence [@pone.0085327-Musumari1], this study is one of the first to quantitatively demonstrate the association of food insecurity with ART nonadherence in a Sub-Saharan African country. Our findings corroborate previous qualitative studies from SSA [@pone.0085327-Sanjobo1], [@pone.0085327-Musumari1]--[@pone.0085327-Hardon1], quantitative studies in resource rich settings [@pone.0085327-Weiser1]--[@pone.0085327-PerettiWatel1], and recent findings from a longitudinal cohort study in rural Uganda [@pone.0085327-Weiser4].

Because of the cross-sectional nature of this study, interpretation of the results could be multiple. Firstly the observed association could be confounded by a third factor that was associated with both ART non-adherence and food insecurity. Secondly, we could assume that ART non-adherence was causal to food insecurity. Lastly, food insecurity could be causal to ART non-adherence.

The first possibility could be the case with poverty as a most likely confounder since prior studies have shown that trade-offs between subsistence needs and health care needs resulted in participants missing clinic visits or giving up ART for food in financially constrained individuals [@pone.0085327-Weiser3], [@pone.0085327-Weiser6]. However, our results failed to support this possibility because household wealth index and employment status were not associated with ART non-adherence in bivariate analyses and our multivariate analysis was adjusted for these variables. Residual confounding of poverty due to insufficient sensitivities of these measures to rate poverty seemed unlikely because both variables were strongly associated with food insecurity (*P*\<0.001). The second possibility seemed also unlikely because such a narrative had never been documented in qualitative studies including our study [@pone.0085327-Sanjobo1], [@pone.0085327-Musumari1]--[@pone.0085327-Hardon1] and because ART non-adherence was not associated with any financial measures such as household wealth index and employment status. The third possibility is therefore most likely the case. This is strongly supported by the recent findings from a study in rural Uganda showing that food insecurity is longitudinally associated with non-adherence to ART [@pone.0085327-Weiser4] and preliminary experimental studies that showed that food supplementation improved the adherence to ART among food-insecure adults in Zambia [@pone.0085327-Cantrell1], [@pone.0085327-Tirivayi1].

However, possible mechanisms through which food insecurity could lead to ART non-adherence remained unclear. Our qualitative study identified two perceptions held by the participants as potential mechanisms including ART can be harmful or is not effective when taken without food [@pone.0085327-Musumari1]. In this study, we tested these hypotheses including the questions on participants' perception on the harmfulness or effectiveness of ART when taken without food but failed to show any association of these perceptions with ART non-adherence. Possible mechanisms may include forgetfulness. Although our study was not designed to compare participants' forgetfulness between the non-adherent and adherent groups as it was asked only as a branch question to the participants who reported ART non-adherence, forgetfulness was cited as one of the most frequent reasons for skipping ART doses in this study. In a qualitative study in Uganda, participants reported forgetting their daily ART doses as a result of spending most of their time working to obtain food [@pone.0085327-Weiser3], suggesting that food insecure individuals may particularly be prone to forgetfulness. In future studies, this hypothesis should be tested by introducing the question on general forgetfulness on daily ART doses for both groups as well as the question on food insecurity and creating an interaction term between the two.

Whatever the exact mechanism, however, the implications of the results of this study could be far-reaching, considering the vast number of people suffering from food insecurity and the estimated 6 million of people living with HIV on ART treatment in SSA [@pone.0085327-Joint1], [@pone.0085327-Institut1], and the fact that food insecurity disproportionately affects HIV-infected individuals [@pone.0085327-Tsai2]--[@pone.0085327-Anema1]. In our study, over half (57%) of our participants were food insecure and alarmingly, most of them were severely insecure, a rate much higher than that previously reported in the general population in Kinshasa City [@pone.0085327-Programme1]. In view of the threat of food insecurity to the long-term success of HIV/AIDS treatment programs in SSA, which hosts the largest number of people on and in need of ART, with a very restricted access to second or third line therapy [@pone.0085327-Joint1], it is crucial to integrate food security strategies into HIV treatment programs [@pone.0085327-World2], [@pone.0085327-United1]. Though, clinic-based short-term intervention studies in SSA have shown promising results for improving patient adherence to ART using food assistance [@pone.0085327-Cantrell1], [@pone.0085327-Tirivayi1]; in order to be sustainable over time, such intervention should be built on a clear understanding of context-specific determinants of food insecurity, and packaged into a holistic approach that takes into account local socio-cultural and structural correlates of ART adherence.

Besides food insecurity our study identified a number of factors associated with ART non-adherence. Consistent with prior studies [@pone.0085327-Johnston1], [@pone.0085327-Horne1], participants who perceived that ART was harmful had higher odds of non-adherence. Most of them believed so because of ART-related side effects, or the fact that ART was a life-long medication. We observed an association between alcohol use and non-adherence to ART. Participants who reported consuming alcohol at least once a month had a 50% increased odds of being non-adherent to ART. This is consistent with previous studies showing that alcohol use negatively affected patient adherence even for moderate levels of consumption [@pone.0085327-Wasti1], [@pone.0085327-Jacquet1]. Our findings also indicated that participants who were on ART for more than 4 years were more likely to be non-adherent compared to those who were placed on ART since less than 4 years. Although this was only significant in bivariate analysis, it still supports previous studies showing that adherence decreases over time [@pone.0085327-Nemes1], [@pone.0085327-Godin2]. Contrary to previous studies [@pone.0085327-Nel1]--[@pone.0085327-Molassiotis1], we found that participants with psychological distress (depression, anxiety) had better adherence compared to those who did not have psychological distress. This uncommon association of psychological distress with better adherence merits further investigation: it is possible that efforts to sustaining ART adherence may over the long-term be source of psychological distress among some patients in the context of DRC, as a result of economic demands and/or sociocultural constraints around antiretroviral medication. Furthermore, a confounding personality trait associated with both psychological distress and ART non-adherence may also explain the observed association. Lastly, it may also be due to the nature of the K-6 scale, which was only validated in a general population in developed settings [@pone.0085327-Kessler1], [@pone.0085327-Furukawa1], [@pone.0085327-Andersen1] but never tested among poor individuals with HIV in developing countries.

This study has both limitations and strengths. First we cannot assume causality of the statistically significant associations with ART adherence in this study given its cross-sectional design. It is possible that unknown or unmeasured factors could have confounded the estimates of the observed associations in our results. Second, results could be biased by socially desirable answers especially in reporting of missed medication pills in the self-reported assessment of ART adherence since the interviews were conducted by health care workers. In order to minimize this potential bias, interviewers were provided extensive training to process the survey questionnaire in a non-judgmental manner and we used a composite measure coupling both subjective (self-reported adherence) and objective (pharmacy refill adherence) measures to assess the overall adherence. On the other hand the strengths of this study include that it is rooted in the results of our qualitative study on patients on ART treatment, retreatment and lost to follow up [@pone.0085327-Musumari1]. In addition, this study derives its data from a large sample of participants selected from geographically diversified recruitment sites, including both public and private health facilities in Kinshasa, DRC. The results of this study therefore may to large extent represent the situation of patients on ART treatment in Kinshasa. However, caution is warranted in generalizing the findings of this study to a broader population. Educational attainment of our sample was higher than the general population of the DRC. Although this could reflect the general trend of HIV prevalence being higher in wealthier socio-economic groups [@pone.0085327-Joint2], it may also be due to the fact that Kinshasa is the country's capital and holds a more educated population.

In summary, we found that food insecurity is a significant risk factor for non-adherence to ART, and is highly prevalent among HIV-infected individuals in Kinshasa, DRC. There is urgent need of integrating effective food security strategies into HIV treatment and care programs to ensure patient adherence to ART and ultimately long-term success of HIV treatment in SSA.
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